A significant advance in cancer research is emerging with the use of VHH fragments to reactivate damaged p53. This essential cancer protector protein is frequently disabled in various types of cancer, resulting https://bookmarkedblog.com/story904917/vhh-fragments-reactivate-tumor-suppressor-p53-new-promising-hope-for-malignant-management